Maria Edebrink
Conseiller Juridique Général chez XBRANE BIOPHARMA AB
Fortune : 4 641 $ au 30/04/2024
Profil
Maria Edebrink currently works at Xbrane Biopharma AB, as Head-Regulatory Affairs & Quality Assurance from 2021.
Ms. Edebrink also formerly worked at Medivir AB, as Head-Regulatory Affairs and AstraZeneca AB, as Head-Regulatory Affairs.
Ms. Edebrink received her graduate degree from the University of Stockholm.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0,02% | 05/09/2023 | 235 210 ( 0,02% ) | 4 641 $ | 30/04/2024 |
Postes actifs de Maria Edebrink
| Sociétés | Poste | Début |
|---|---|---|
| XBRANE BIOPHARMA AB | Conseiller Juridique Général | 01/01/2019 |
Anciens postes connus de Maria Edebrink
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIVIR AB | Conseiller Juridique Général | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Conseiller Juridique Général | - |
Formation de Maria Edebrink
| University of Stockholm | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| XBRANE BIOPHARMA AB | Health Technology |
| MEDIVIR AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |